MicroRNA 3126 (miR-3126)

MicroRNA 3126 (miR-3126) is a member of the microRNA (miRNA) family, which consists of small, non-coding RNAs—typically 20–24 nucleotides in length—that regulate gene expression in multicellular organisms by binding to complementary sequences in target mRNAs, leading to translational repression or mRNA degradation. Like other miRNAs, miR-3126 exerts regulatory effects at the post-transcriptional level, but there is currently no published functional, disease, or drug information specifically for miR-3126 itself. Additional context: - Both functional and disease associations are established only for the general class of microRNAs, not specifically for miR-3126. - No evidence from available sources supports MIR3126 as a therapeutic target (receptor, enzyme, transporter, etc.), a biomarker, or a molecule with known interacting drugs. - There is a lack of primary literature or database entries detailing the biological or disease role, mechanism, or safety concerns for miR-3126 specifically. Reasoning for "is_incorrect": - While MIR3126 is a valid microRNA locus, there is no evidence it is a therapeutic target or has established biological or clinical relevance at this time. - Most entries for MIR3126 are only in gene and RNA sequence databases, indicating insufficient functional characterization. Summary: MicroRNA 3126 (MIR3126, miR-3126, hsa-miR-3126) is a short, non-coding RNA predicted to function in gene expression regulation like other miRNAs, but there is no specific information available on its targets, disease association, therapeutic relevance, or interactions. Its use as a named molecular target is likely premature or incorrect given the absence of functionally validated data.

Other names

hsa-miR-3126MIR3126mir-3126hsa-mir-3126